Mission
OUR MISSION IS TO STIMULATE THE DISCOVERY AND DEVELOPMENT OF INNOVATIVE THERAPIES FOR THE TREATMENT, CONTROL, CURE, AND PREVENTION OF CANCER. THIS MISSION IS ACCOMPLISHED THROUGH GRANTS TO FUND CLINICAL AND SCIENTIFIC RESEARCH.
Public Charity
THE CHEMOTHERAPY FOUNDATION INC
THE CHEMOTHERAPY FOUNDATION INC is a Public Charity headquartered in NEW YORK, NY. Financial data from the 2023 filing: $80K revenue, $375K expenses, $317K total assets. 18 publicly reported grants to this organization, totaling roughly $160K, appear in IRS filings.
EIN: 132622978
NEW YORK, NY
Latest filing: 2023
Total Revenue$80K
Total Expenses$375K
Total Assets$317K
Grant Records18
Funding Total$160K
Filing Years2018–2023
Where $100 goes at The Chemotherapy Foundation Inc
How The Chemotherapy Foundation Inc divides every $100 it spends, from its own Form 990 filings, averaged across 6 years.
$55
Programs
the work itself
$23
Management
running the organization
$22
Fundraising
raising the next dollar
Inside the $55 for programs
$55
Research grant programthe grant program focuses on supporting basic science and clinical research with translational potential for near-term benefit to improve patient care and survival
Source: Form 990 filings with the IRS, latest fiscal year 2023. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
EDUCATION
$20,000
$6,750
For grant recipient's exempt purposes
$5,680
For grant recipient's exempt purposes
$13,500
EDUCATION
$7,500
Showing up to 5 of 18 total records — full history available with membership.
Officers & Directors
TREASURER/SECRETARY
Craig J Goldberg
TRUSTEE
Eric S Richter
CHAIR OF THE BOARD
Michael G Rosenberg
EXECUTIVE DIRECTOR
Paola G Muggia
TRUSTEE
Peter Alkalay
TRUSTEE
Suzanne M Miller Phd
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $80K | $375K | $317K |
| 2022 | $178K | $464K | $510K |
| 2020 | $167K | $430K | $915K |
| 2019 | $330K | $1.0M | $1.3M |
| 2018 | $471K | $1.1M | $1.9M |
Between 2018 and 2023, reported annual revenue declined from $471K to $80K (-83%), with total assets most recently reported at $317K.
Interactive year-over-year charts and full filing details available with membership.